Keywords: sepracor, reports, preliminary, ph, ii, sep-225441, results

Sepracor reports preliminary Ph II SEP-225441 results in GAD

Article | 16 March 2009

Print This

USA firm Sepracor has completed the analysis and validation of the preliminary results of a Phase II, 440-patient study evaluating ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in